Screen2Prevent (S2P)
Recruiting · NCT07728123 · Interventional (participants receive a specific treatment) · Lead sponsor: Westat
View the official record on ClinicalTrials.gov →Interventions studied
HIV screening strategies
What this trial is about
Screen2Prevent is a study intended to improve HIV prevention and detection through implementation and evaluation of three different broad-scale HIV screening approaches a) targeted, b) universally offered opt-in, and c) universally offered opt-out in Emergency Departments (EDs) by leveraging digital health to identify and link adolescents seeking care in the ED to HIV Pre-Exposure Prophylaxis (PrEP)/Antiretroviral treatment (ART).
Who can take part
Age range
14 Years to 24 Years
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Age 14-24 years, inclusive
- Present to the participating ED, regardless of chief complaint during the study period
Exclusion criteria
- None
Where it is running
5 locations listed across 5 US states.
- University of South Florida - Tampa, Florida, United States
- Emory Atlanta Adolescent Consortium - Atlanta, Georgia, United States
- Johns Hopkins University - Baltimore, Maryland, United States
- St. Jude Children's Research Hospital - Memphis, Tennessee, United States
- Baylor College of Medicine - Houston, Texas, United States